- GlobeNewswire•7 days ago
COLUMBIA, Md., Aug. 17, 2016-- Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market.. As previously disclosed, on ...
- GlobeNewswire•19 days ago
What: Osiris Therapeutics, Inc., the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will ...
- GlobeNewswire•20 days agoGrafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal
COLUMBIA, Md., Aug. 04, 2016-- Osiris Therapeutics, Inc., a leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and ...
Osiris Therapeutics, Inc. (OSIR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||4.97 x 2700|
|Ask||4.99 x 1300|
|Day's Range||4.95 - 5.25|
|52wk Range||3.55 - 20.42|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||118.33|
|Avg Vol (3m)||86,832|
|Dividend & Yield||0.00 (0.00%)|